Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Clinical Nuclear Medicine|January 23, 2018
Tumor Cystic Necrosis Following Peptide Receptor Radionuclide Therapy in Neuroendocrine TumorsRahul Ladwa, Hooi Wen Hong, David Wyld, et al.Cancer Treatment and Research Communications|October 28, 2022
The impact of frailty on health outcomes in older adults with lung cancer: A systematic reviewJames A Fletcher, Sarah T Fox, Natasha Reid, et al.Oral Oncology|February 1, 2026
Tumour microenvironment diversity of HNSCC and the molecular landscape of recurrent diseaseKatelyn Steele, Catherine Barnett, Rahul Ladwa, et al.Journal of Geriatric Oncology|December 16, 2025
Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patientsRochelle Sheppard, Christopher Anstey, Leila Hanjani, et al.JAMA Dermatology|February 12, 2025
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer PreventionCharlotte Cox, Susan Brown, Euan Walpole, et al.Lung Cancer Management|August 11, 2020
Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancerRahul Ladwa, Kate E Roberts, Connor O'Leary, et al.Asia-Pacific Journal of Clinical Oncology|December 17, 2015
Frontline treatment of epithelial ovarian cancerJeffrey Goh, G Raj Mohan, Rahul Ladwa, et al.Frontiers in Oncology|February 7, 2022
The Role of Circulating Biomarkers in Lung CancerSayuri Herath, Habib Sadeghi Rad, Payar Radfar, et al.BMC Cancer|June 2, 2023
How frail is frail in oncology studies? A scoping reviewJames A Fletcher, Benignus Logan, Natasha Reid, et al.Cancers|July 27, 2024
Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand PerspectiveRahul Ladwa, Gerald Fogarty, Peggy Chen, et al.Pageof 7